Methods for the evaluation of drug action at the human melatonin receptor subtypes

NeuroSignals

Volumn 8, Issue 1-2, 1999, Pages 32-40

  Nonno, Romolo ^a   Fraschini, Franco ^a   Stankov, Bojidar M ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Intrinsic activity; Melatonin; Melatonin analogues; Melatonin receptor antagonists; Mt1 and MT2 receptors; 35S GTP S binding

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; HORMONE ANALOG; HORMONE RECEPTOR BLOCKING AGENT; LUZINDOLE; MELATONIN; MELATONIN RECEPTOR; RECEPTOR SUBTYPE;

BINDING AFFINITY; CELL STRAIN 3T3; DRUG ACTIVITY; DRUG POTENCY; FIBROBLAST; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MOLECULAR CLONING; REVIEW;

3T3 CELLS; ANIMALS; BINDING, COMPETITIVE; GTP-BINDING PROTEINS; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HUMANS; KINETICS; MELATONIN; MICE; RECEPTORS, CELL SURFACE; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, MELATONIN; RECOMBINANT PROTEINS; TRANSFECTION;

EID: 0033056103     PISSN: 1424862X     EISSN: 14248638     Source Type: Journal    
DOI: 10.1159/000014566     Document Type: Article

References (23)

1. Nonno R, Lucini V, Pannacci M, Mazzucchelli C, Angeloni D, Fras-chini F, Stankov BM: Pharmacological characterization of the human Mel1a receptor following stable tranfection into NIH3T3 cells. Br J Pharmacol 1998;124:485-492.
2. Vanecek J: Cellular mechanisms of melatonin action. Physiol Rev 1998; 78:687-721.
3. Depreux P, Lesieur D, Mansour HA, Morgan P, Howell HE, Renard P, Caignard DH, Pfeiffer B, Dela-grange P, Guardiola B, Yous S, Demarque A, Adam G, Andrieux J: Synthesis and structure-activity relationships of novel naphthalenic and bioisosteric related amidic derivatives as melatonin receptor ligands. J Med Chem 1994;37:3231-3239.
4. Tarzia G, Diamantini G, Di Giacomo B, Spadoni G, Esposti D, Nonno R, Lucini V, Pannacci M, Fraschini F, Stankov BM: 1-(2-Alkanamido-ethyl)-6-methoxyindole derivatives: A new class of potent indole melatonin analogues. J Med Chem 1997; 40:2003-2010.
5. Sugden D: Aggregation of pigment granules in single cultured Xenopus laevis melanophores by melatonin analogues. Br J Pharmacol 1991; 104:922-927.
6. Ebisawa T, Karne S, Lerner MR, Reppert SM: Expression cloning of a high affinity melatonin receptor from Xenopus dermal melano-phores. Proc Natl Acad Sci USA 1994;91:6133-6137.
7. Davies DJ, Garratt PJ, Tocher DA, Vonhoff S, Davies J, Teh MT, Sug-den D: Mapping the melatonin receptor. 5. Melatonin agonists and antagonists derived from tetrahy-drocyclopent[b] indoles, tetrahydro-carbazoles and hexahydrocyclopent-[b]indoles. J Med Chem 1998;41: 451-467.
8. Dubocovich ML: Melatonin is a potent modulator of dopamine release in the retina. Nature 1983;306:782-784.
9. Dubocovich ML, Masana M, Iacob S, Sauri D: Melatonin receptor antagonists that differentiate between the human Mel1a and Mel1b recombinant subtypes are used to assess the pharmacological profile of the rabbit retina ML1 presynaptic heteroreceptor. Naunyn-Schmiedeberg’s Arch Pharmacol 1997;355:365-375.
10. Reppert SM, Weaver DR, Ebisawa T: Cloning and characterization of a mammalian melatonin receptor that mediates reproductive and circadian responses. Neuron 1994;13: 1177-1185.
11. Reppert SM, Godson C, Mahle CD, Weaver DR, Slaugenhaupt SA, Gu-sella JF: Molecular characterization of a second melatonin receptor expressed in human retina and brain: the Mel1b melatonin receptor. Proc Natl Acad Sci USA 1995;92:8734-8738.
12. Birnbaumer L, Abramowitz J, Brown AM: Receptor-effector coupling by G proteins. Biochim Bio-phys Acta 1990;1031:163-224.
13. Hilf G, Giershik P, Jakobs KH: Muscarinic acetylcholine receptor-stimulated binding of guanosine 5’-O-β-thiotriphosphate to guanine nucleotide-binding proteins in cardiac membranes. Eur J Biochem 1989;186:725-731.
14. 35S]thio)triphosphate binding. Mol Pharmacol 1993;44:115-123.
15. 2-adrenergic receptor activation of G proteins: Evidence for a precoupled receptor/G protein state. Mol Pharmacol 1994;45:524-531.
16. 35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells. Mol Pharmacol 1995;47:848-854.
17. Adham N, Ellerbrock B, Hartig P, Weinshank RL, Branchek T: Receptor reserve mask partial agonist activity of drugs in a cloned rat 5-hydroxytryptamine1B receptor expression system. Mol Pharmacol 1993;43:427-433.
18. 2-Adrenoceptor regulation of adenylyl cyclase in CHO cells: Dependence on receptor density, receptor subtype and present activity of adenylyl cyclase. Eur J Pharmacol 1997;335:53-63.
19. 35S]GTPyS binding. Eur J Pharmacol 1997;320: 267-275.
20. Bradford M: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72: 248-254.
21. Costa T, Lang J, Gless C, Herz A: Spontaneous association between opioid receptors and GTP-binding regulatory proteins in native membranes: Specific regulation by antagonist and sodium ions. Mol Pharmacol 1990;37:383-394.
22. Lew MJ, Angus JA: Analysis of competitive agonist-antagonist interactions by nonlinear regression. Trends Pharmacol Sci 1990; 16: 328-337.
23. Venter DP: Efficacy. I. A new method for estimating relative efficacy of full agonists via a newly defined efficacy-related parameter. Eur J Pharmacol 1997;320:223-231.